http://www.fda.gov/cder/drug/antidepressants/default.htm
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
The Food and Drug Administration (FDA) asks manufacturers of all antidepressant drugs to include in their labeling a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality (suicidal thinking and behavior) in children and adolescents being treated with these agents, and additional information about the results of pediatric studies. These antidepressants include Celexa (citalopram HBr), Effexor (venlafaxine HCl), Paxil (paroxetine HCl), Prozac (fluoxetine HCl), Wellbutrin (bupropion HCl), and Zoloft (sertraline HCl), to name just a few.